Skip to the content
REVOLUTIONIZING TREATMENT DECISIONS
Follow us on
  • Home
  • Solutions
    • INNOVATIVE TRIAL DESIGN
    • Inform Strategic Decisions
    • Holistic Data Analysis
    • Personalize Treatment Assessment
  • Resources
    • Net Treatment Benefit
    • Regulatory submissions
    • Blogs
    • Case studies
    • Peer-reviewed papers
  • About
    • About One2Treat
    • One2Treat’s Team
    • Contact
  • Careers
Get in touch
  • Home
  • Solutions
    • INNOVATIVE TRIAL DESIGN
    • Inform Strategic Decisions
    • Holistic Data Analysis
    • Personalize Treatment Assessment
  • Resources
    • Net Treatment Benefit
    • Regulatory submissions
    • Blogs
    • Case studies
    • Peer-reviewed papers
  • About
    • About One2Treat
    • One2Treat’s Team
    • Contact
  • Careers
Our resources

Peer-Reviewed Papers

  • All
  • Best Practices
  • Methodological papers
  • Trial Analysis
  • Trial Designs
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week
Best Practices
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week
READ MORE →
The tyranny of non-inferiority trials
Best Practices
The tyranny of non-inferiority trials
READ MORE →
How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials
Best Practices
How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials
READ MORE →
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
Best Practices
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?
READ MORE →
The Net Benefit of a treatment should take the correlation between benefits and harms into account
Best Practices
The Net Benefit of a treatment should take the correlation between benefits and harms into account
READ MORE →
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
Best Practices
The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials
READ MORE →

Want to invest in a more holistic understanding
of net treatment benefit?


Get in touch

SOLUTIONS

  • Innovative Trial Design
  • Holistic Data Analysis
  • Market Access and HTA
  • Shared Decision Making

ABOUT

  • About One2Treat
  • One2Treat’s Team
  • Contact

RESOURCES

  • Learn more about Net Treatment Benefit
  • Case studies
  • Regulatory submissions
  • PRs, podcasts & webinars
  • Scientific papers
Copyright © 2024 — One2Treat
Privacy Policy